Skip to main content
. 2015 Nov-Dec;77(6):764–770. doi: 10.4103/0250-474x.174970

Fig. 4.

Fig. 4

Release rate profile of dexamethasone sodium phosphate from in situ gelling system containing Natrasol 250.

Release rate profile of dexamethasone sodium phophate from in situ otic formulations P3N1 (Inline graphic), P3N2 (Inline graphic) and P3N3 (Inline graphic) containing poloxamer (19% w/v) with Natrasol 250 (0.5, 1.0 and 1.5% w/v), respectively. Results are mean of three observations, ±standard deviation.